Kayyem Jon Faiz 的 Form 4 申報
Inhibrx Biosciences, Inc.（INBX），2024/6/4 申報
- 申報編號
- 0002007919-24-000006
- 申報時間
- 2024/6/4
- 交易日
- 2024/5/31-6/4
- 申報延遲
- 4 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 5 筆非衍生性交易。公開市場買進合計 $492.8 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Kayyem Jon FaizCIK 0001366268 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/5/31 | Common Stock | P買進取得 | +70,193 | $16.14F1 | +$1,132,915.02 | 876,268 | 間接 | |
| 2024/6/3 | Common Stock | P買進取得 | +46,792 | $16.61F2 | +$777,215.12 | 923,060 | 間接 | |
| 2024/6/3 | Common Stock | P買進取得 | +80,738 | $17.90F3 | +$1,445,210.2 | 1,003,798 | 間接 | |
| 2024/6/4 | Common Stock | P買進取得 | +65,337 | $17.44F4 | +$1,139,477.28 | 1,069,135 | 間接 | |
| 2024/6/4 | Common Stock | P買進取得 | +23,726 | $18.24F5 | +$432,762.24 | 1,092,861 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The shares were purchased in multiple transactions at prices ranging from $15.75 to $16.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F2
The shares were purchased in multiple transactions at prices ranging from $16.25 to $16.75, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The shares were purchased in multiple transactions at prices ranging from $17.40 to $18.10, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The shares were purchased in multiple transactions at prices ranging from $17.01 to $18.00, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The shares were purchased in multiple transactions at prices ranging from $18.01 to $18.50, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
表 I 有 1 筆交易的價格引用這則附註。